Whether you are at high risk of heart disease, managing an existing diabetic condition, or using GLP-1 drugs sold under brand names of (Ozempic, Wegovy, Mounjaro, Zepbound) or their generics (Semaglutide or Tirzepatide) for diabetes or weight loss, the Cardi-A1c panel is both appropriate and recommended. This panel is specifically designed to monitor the benefits of GLP-1 usage in reducing A1c levels and preventing cardiovascular events such as heart attack, stroke, or death.
Hey practitioners! 👋 Join Dr. Aristo Vojdani, PhD, MSc, CLS, for an insightful webinar, "Beyond Exposure: Understanding Immune Reactivity Patterns," on Thursday, August 7 at 12:00 PM EST / 9:00 AM PT.
In this session, you’ll explore how immune reactivity testing may provide additional insights into how the body responds to environmental compounds, food additives, and microbial byproducts. Dr. Vojdani will walk through key Cyrex panels that offer complementary perspectives to traditional exposure assessments, supporting clinicians in recognizing immune response patterns that may inform personalized wellness and functional care strategies.
Register now to secure your spot.
.png)
.svg){kind=small}
.svg){kind=small}
